FHI 360 is a global leader in cutting-edge HIV prevention research, connecting research to practice, which includes generating evidence on the safety and effectiveness of drugs and other HIV prevention technologies.
FHI 360 serves as the Coordinating and Operations Center for the HIV Prevention Trials Network (HPTN). HPTN is a worldwide collaborative clinical trials network that develops and tests the safety and efficacy of interventions designed to prevent the transmission of HIV.
Additionally, through the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) project, funded by PEPFAR and USAID, FHI 360 is helping adolescent girls, young women and other women protect themselves from HIV.
FHI 360 leads the MOSAIC consortium, which is accelerating the introduction and scale-up of new and emerging biomedical HIV prevention products. MOSAIC works across multiple countries to implement user-centered research and research translation efforts to identify and remove barriers to new product introduction, access and use. To further support the introduction and scale-up of HIV prevention products, MOSAIC also provides technical assistance and strengthens local partners’ capacities.
Learn more by reviewing resources created by the MOSAIC project.